Abstract
Cardiovascular Nanomedicines: A Review of Nanoparticle-Mediated Strategies for Disease Treatment
Kalyani Dhatadak1, Pragati Bhalerao1, Sakshi Soni1, Manojkumar Mahajan2, Aman Upaganlawar3, Chandrashekhar Upasani4
1 Research Scholar, Department of Pharmacology, SNJBs Shriman Sureshdada Jain College of Pharmacy, Chandwad, Nashik, India
2 Associate Professor, Department of Pharmacology, SNJBs Shriman Sureshdada Jain College of Pharmacy, Chandwad, Nashik, India
3 Professor and Head, Department of Pharmacology, SNJBs Shriman Sureshdada Jain College of Pharmacy, Chandwad, Nashik, India
4 Professor and Principal, SNJBs Shriman Sureshdada Jain College of Pharmacy, Chandwad, Nashik, India
View: 40
|Download: 54
Abstract
Worldwide, cardiovascular diseases (CVDs) are the leading cause of mortality, demanding innovative therapeutic strategies. Nanomedicine offers promising solutions through nanoparticle-mediated drug delivery, enhancing precision, efficacy, and safety. This review examines nanocarriers, including liposomes, polymeric nanoparticles, and dendrimers, for targeted CVD treatment, encompassing coronary artery disease, atherosclerosis, and myocardial infarction. This review highlights advances in theranostics, gene therapy, and stimuli-responsive systems while addressing challenges related to biocompatibility and clinical translation. Nanotechnology holds transformative potential for CVD management, enabling personalized and least invasive treatments.